Cellular 5'-3' mRNA exonuclease Xrn1 controls double-stranded RNA accumulation and anti-viral responses

Cell Host & Microbe
Hannah M Burgess, I Mohr

Abstract

By accelerating global mRNA decay, many viruses impair host protein synthesis, limiting host defenses and stimulating virus mRNA translation. Vaccinia virus (VacV) encodes two decapping enzymes (D9, D10) that remove protective 5' caps on mRNAs, presumably generating substrates for degradation by the host exonuclease Xrn1. Surprisingly, we find VacV infection of Xrn1-depleted cells inhibits protein synthesis, compromising virus growth. These effects are aggravated by D9 deficiency and dependent upon a virus transcription factor required for intermediate and late mRNA biogenesis. Considerable double-stranded RNA (dsRNA) accumulation in Xrn1-depleted cells is accompanied by activation of host dsRNA-responsive defenses controlled by PKR and 2'-5' oligoadenylate synthetase (OAS), which respectively inactivate the translation initiation factor eIF2 and stimulate RNA cleavage by RNase L. This proceeds despite VacV-encoded PKR and RNase L antagonists being present. Moreover, Xrn1 depletion sensitizes uninfected cells to dsRNA treatment. Thus, Xrn1 is a cellular factor regulating dsRNA accumulation and dsRNA-responsive innate immune effectors.

References

Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H W ChangB L Jacobs
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A D Kwong, N Frenkel
Sep 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·Y Aloni
Oct 6, 1972·Biochemical and Biophysical Research Communications·J J Lucas, H S Ginsberg
Jan 30, 2004·Nature Structural & Molecular Biology·Roy Parker, Haiwei Song
Nov 22, 2005·EMBO Reports·Georg StoecklinPaul Anderson
Aug 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wataru KamitaniShinji Makino
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Nicole L GarneauCarol J Wilusz
Feb 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Susan ParrishBernard Moss
Sep 21, 2007·Journal of Virology·Susan Parrish, Bernard Moss
Feb 5, 2008·Molecular Cell·Christian Kroun DamgaardJørgen Kjems
Apr 15, 2008·Cell Host & Microbe·Carla J Beckham, Roy Parker
Jun 26, 2008·Nature Reviews. Immunology·Anthony J Sadler, Bryan R G Williams
Oct 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eun Joo SeoThomas E Dever
Aug 27, 2010·Journal of Virology·Patrícia A G C SilvaPeter J Bredenbeek
Oct 22, 2010·Journal of Virology·Jonathan D DoughertyRichard E Lloyd
Mar 3, 2011·Molecular Cell·Martin JinekJennifer A Doudna
Jul 1, 2010·Wiley Interdisciplinary Reviews. RNA·Marta Maria Gaglia, Britt A Glaunsinger
Oct 18, 2011·Nature Reviews. Microbiology·Derek Walsh, Ian Mohr
Jan 19, 2012·Molecular and Cellular Biology·You LiMegerditch Kiledjian
Jun 29, 2012·Journal of Virology·Marta Maria GagliaBritt A Glaunsinger
Jun 29, 2012·Journal of Virology·Robin D WarrenBernard Moss
Sep 6, 2012·The Journal of Infectious Diseases·Iana H HaralambievaGregory A Poland
Oct 23, 2012·Cell Host & Microbe·Ian Mohr, Nahum Sonenberg
Nov 13, 2012·Nature Structural & Molecular Biology·Joerg E BraunElisa Izaurralde
Nov 14, 2012·Annual Review of Genetics·Matthew D Daugherty, Harmit S Malik
Dec 5, 2012·Cold Spring Harbor Perspectives in Biology·Derek WalshIan Mohr
Jan 5, 2013·Biochimica Et Biophysica Acta·Marcos Arribas-LaytonHaiwei Song
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Gilad SivanBernard Moss
Mar 23, 2013·Biochimica Et Biophysica Acta·Vinay K NagarajanPamela J Green
Jul 11, 2013·Cold Spring Harbor Perspectives in Biology·Bernard Moss
Aug 1, 2013·Wiley Interdisciplinary Reviews. RNA·G Sullivan Read

❮ Previous
Next ❯

Citations

Mar 15, 2015·Cell Host & Microbe·Robert H Silverman
Aug 2, 2015·Current Opinion in Virology·Melissa Drappier, Thomas Michiels
Dec 9, 2015·Reviews in Medical Virology·Hiroyuki OshiumiTakuji Daito
Apr 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hannah M Burgess, Ian Mohr
Jun 18, 2016·Viruses·Jason Liem, Jia Liu
Oct 7, 2016·PLoS Pathogens·Paul A RowleySara L Sawyer
Aug 9, 2016·Annual Review of Virology·Eric JanDerek Walsh
Aug 9, 2017·Viruses·Daniel Brian NicholsJessica Cottrell
Dec 22, 2017·Journal of Virology·Stephanie J ChildAdam P Geballe
May 12, 2018·Future Virology·Liang GuoPaul R Bohjanen
Nov 2, 2018·Wiley Interdisciplinary Reviews. RNA·Nathan MeadeDerek Walsh
Jun 13, 2018·Cold Spring Harbor Perspectives in Biology·Noam Stern-GinossarIan Mohr
Jun 8, 2017·Nucleic Acids Research·Reka A HarasztiAnastasia Khvorova
Dec 18, 2019·Proceedings of the National Academy of Sciences of the United States of America·Rosa M Rubio, Ian Mohr
Dec 16, 2017·International Journal of Molecular Sciences·Takeo Wada, Attila Becskei
Jun 3, 2017·Nucleic Acids Research·Dorota MatelskaKrzysztof Ginalski
Nov 7, 2018·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sylwia BednarekJacek Jemielity
Apr 8, 2020·World Journal of AIDS·William De MartiniSulie L Chang
Feb 9, 2021·Nucleic Acids Research·Agnes KarasikNicholas R Guydosh
Feb 24, 2021·RNA Biology·Lukasz MarkiewiczPawel J Sikorski
Apr 7, 2018·Virology·Sarah E HicksonAdam P Geballe
Sep 29, 2021·PloS One·Grace Kago, Susan Parrish
Sep 14, 2021·Molecular and Cellular Biology·Elizabeth L CastleJennifer A Corcoran
Nov 3, 2021·Proceedings of the National Academy of Sciences of the United States of America·Elizabeth I VinkIan Mohr
Jun 26, 2021·Genes & Development·Hannah M BurgessIan Mohr

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
fluorescence microscopy
transfections

Software Mentioned

Zen
Li
Genelink
Cor Image Studio

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.